Ignite Creation Date:
2024-05-05 @ 11:41 PM
Last Modification Date:
2024-10-26 @ 10:38 AM
Study NCT ID:
NCT01393678
Status:
COMPLETED
Last Update Posted:
2011-07-13
First Post:
2011-07-03
Brief Title:
Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease
Sponsor:
PharmaKing
Organization:
PharmaKing
Study Overview
Official Title:
A Multicenter Randomized Double-blind 2 Parallel Group Phase 3 Study of PENNEL Capsule in Chronic Liver Disease
Status:
COMPLETED
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The drug in this study is combined product of biphenyl dimethyl dicarboxylate DDB and garlic oil This components showed synergistic enhancing effects in previous tests In phase 2 test 6 cap three times a day dosage 2cap TID is better than other dosage Based on above this study is phase 3 test to prove efficacy and safety of PENNEL
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None